Cleared Traditional

HDF Assist Mudule, HDF Infusion Set and Substitution Filter (K210575) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K210575 · Nephros · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
441d
Days
Class 2
Risk

K210575 is an FDA 510(k) clearance for the HDF Assist Mudule, HDF Infusion Set and Substitution Filter. Classified as Dialyzer, High Permeability With Or Without Sealed Dialysate System (product code KDI), Class II - Special Controls.

Submitted by Nephros (South Orange, US). The FDA issued a Cleared decision on May 13, 2022 after a review of 441 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5860 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Nephros devices

Submission Details

510(k) Number K210575 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 2021
Decision Date May 13, 2022
Days to Decision 441 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
311d slower than avg
Panel avg: 130d · This submission: 441d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 77
Devices cleared under the same product code (KDI) and FDA review panel - the closest regulatory comparables to K210575.
SC+ Hemodialysis Device, SC+ Dialysate Cartridge, SC+ Blood Tube Set
K222067 · Quanta Dialysis Technologies, Ltd. · Nov 2022
2008T BlueStar Hemodailysis Machine
K222952 · Fresenius Medical Care Renal Therapies Group, LLC · Oct 2022
Tablo Hemodialysis System
K211370 · Outset Medical, Inc. · Jul 2022
Prismaflex ST60 Set, Prismaflex ST100 Set, Prismaflex ST150 set
K212216 · Baxter Healthcare Corporation · Apr 2022
Revaclear 500, Revaclear 400, Revaclear 300
K213639 · Baxter Healthcare Corporation · Jan 2022
SC+ Hemodialysis Machine, SC+ Dialysate Cartridge, SC+ Blood Tubeset
K210661 · Quanta Dialysis Technologies, Ltd. · Aug 2021